Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05380531 · ClinicalTrials.gov registry record · NA

Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section

A NA study of Opioid Use and Cesarean Section Complications, sponsored by Senthil Sadhasivam.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
2
Study locations

NCT05380531 is a NA study of Opioid Use and Cesarean Section Complications that is actively recruiting participants, run by Senthil Sadhasivam. The registered enrollment target is 600 participants, below the 148,254-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05380531, a NA study of Opioid Use and Cesarean Section Complications, is actively recruiting participants, sponsored by Senthil Sadhasivam.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this collaborative CTSA (Clinical and Translational Science Award) application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in breastfeeding mothers and their infants

Interventions

  • DIAGNOSTIC_TEST Preoperative Genotyping

Study Locations (2)

Pennsylvania

  • UPMC Magee Women's Hospital - Pittsburgh
  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2022-12-05
Est. Completion 2026-10-30
Phase NA

Sponsor

Senthil Sadhasivam

7 total trials

What the Registry Record Tells You About NCT05380531

The ClinicalTrials.gov registry entry for NCT05380531 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,254-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Senthil Sadhasivam, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which Preoperative Genotyping is the first listed.

NCT05380531 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05380531 about?

NCT05380531 is a clinical study titled "Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section". The purpose of this collaborative CTSA (Clinical and Translational Science Award) application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in breastfeeding mothe...

What is the current status of trial NCT05380531?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2022-12-05. Estimated completion is 2026-10-30.

What conditions does trial NCT05380531 study?

This clinical trial studies the following conditions: Opioid Use, Cesarean Section Complications.

What interventions are being tested in trial NCT05380531?

The interventions under investigation include: Preoperative Genotyping (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05380531?

This trial is sponsored by Senthil Sadhasivam, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05380531 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.